Insider Transactions in Q4 2023 at Moon Lake Immunotherapeutics (MLTX)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 20
2023
|
Matthias Bodenstedt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,264
-1.0%
|
$305,312
$58.34 P/Share
|
|
Dec 19
2023
|
Matthias Bodenstedt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
94,736
-15.26%
|
$5,589,424
$59.22 P/Share
|
|
Oct 05
2023
|
Bihua Chen |
BUY
Open market or private purchase
|
Indirect |
58,839
+0.69%
|
$3,471,501
$59.9 P/Share
|
|
Oct 04
2023
|
Bihua Chen |
BUY
Open market or private purchase
|
Indirect |
67,814
+0.8%
|
$3,865,398
$57.32 P/Share
|
|
Oct 03
2023
|
Bihua Chen |
BUY
Open market or private purchase
|
Indirect |
150,487
+1.77%
|
$8,577,759
$57.25 P/Share
|
|
Oct 02
2023
|
Bihua Chen |
BUY
Open market or private purchase
|
Indirect |
74,911
+0.9%
|
$4,269,927
$57.37 P/Share
|
|
Oct 01
2023
|
Matthias Bodenstedt Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
62,972
-17.62%
|
-
|
|
Oct 01
2023
|
Matthias Bodenstedt Chief Financial Officer |
BUY
Conversion of derivative security
|
Direct |
62,972
+9.21%
|
-
|
|
Oct 01
2023
|
Simon Sturge Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
342,980
-100.0%
|
-
|
|
Oct 01
2023
|
Simon Sturge Director |
BUY
Conversion of derivative security
|
Direct |
342,980
+50.0%
|
-
|
|
Oct 01
2023
|
Kristian Reich Chief Scientific Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
41,981
-17.62%
|
-
|
|
Oct 01
2023
|
Kristian Reich Chief Scientific Officer |
BUY
Conversion of derivative security
|
Direct |
41,981
+23.06%
|
-
|
|
Oct 01
2023
|
Kristian Reich Chief Scientific Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
2,527,477
-100.0%
|
-
|
|
Oct 01
2023
|
Kristian Reich Chief Scientific Officer |
BUY
Conversion of derivative security
|
Indirect |
2,527,477
+45.5%
|
-
|
|
Oct 01
2023
|
Da Silva Jorge Santos Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,167,554
-69.59%
|
-
|
|
Oct 01
2023
|
Da Silva Jorge Santos Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
3,167,554
+27.12%
|
-
|